Senior insider sale
ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$1.01M
11.60K shares
What this filing means
PERRY MICHAEL S plans to sell 11.60K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $1.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001628280-26-057767
Director
Since Jan 2019
11.60K
Shares to sell
$1.01M
Approx. market value
11.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Compensation
Compensation
12/18/2025
600.00Compensation
Compensation
1/1/2022
9KCompensation
Compensation
1/1/2021
2KTotal acquired11.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/18/2025 | Compensation Compensation | 600.00 | — |
1/1/2022 | Compensation Compensation | 9K | — |
1/1/2021 | Compensation Compensation | 2K | — |
| Total | 11.60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.60K
Market value
$1.01M
8/18/2026
Total
Units
11.60K
Value
$1.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2026 | 11.60K | $1.01M | NASDAQ | Planned |
| Total | 11.60K | $1.01M | ||